Shedir Pharma Group S.p.A. (BIT: SHE)
Italy
· Delayed Price · Currency is EUR 4.880
0.00 (0.00%)
Jan 20, 2025, 5:02 PM CET
Shedir Pharma Group Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Operating Revenue | 60.96 | 59.39 | 53.48 | 44.74 | 43.05 | 50.22 | Upgrade
|
| Other Revenue | - | - | - | - | 0.15 | 0.47 | Upgrade
|
| Revenue | 60.96 | 59.39 | 53.48 | 44.74 | 43.19 | 50.69 | Upgrade
|
| Revenue Growth (YoY) | 4.34% | 11.05% | 19.53% | 3.59% | -14.79% | 7.06% | Upgrade
|
| Cost of Revenue | 42.05 | 41.02 | 37.28 | 30.88 | 30.4 | 34.9 | Upgrade
|
| Gross Profit | 18.91 | 18.37 | 16.2 | 13.87 | 12.79 | 15.79 | Upgrade
|
| Selling, General & Admin | 6.24 | 5.76 | 5.13 | 4.36 | 4.17 | 5.13 | Upgrade
|
| Other Operating Expenses | 0.09 | 0.38 | -0.08 | 1.65 | 0.87 | 1.21 | Upgrade
|
| Operating Expenses | 10.17 | 10 | 7.91 | 8.54 | 7.31 | 8.3 | Upgrade
|
| Operating Income | 8.74 | 8.37 | 8.3 | 5.33 | 5.48 | 7.49 | Upgrade
|
| Interest Expense | -0.25 | -0.31 | -0.25 | -0.24 | -0.22 | -0.41 | Upgrade
|
| Interest & Investment Income | 0.1 | 0.01 | 0.2 | 0.03 | 0.03 | 0.05 | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | - | 0.08 | - | - | Upgrade
|
| EBT Excluding Unusual Items | 8.59 | 8.08 | 8.25 | 5.2 | 5.29 | 7.13 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | - | -0.47 | - | Upgrade
|
| Asset Writedown | - | - | - | - | - | -0.51 | Upgrade
|
| Other Unusual Items | - | - | - | 0.5 | 0.49 | -1.72 | Upgrade
|
| Pretax Income | 8.59 | 8.08 | 8.25 | 5.7 | 5.31 | 4.91 | Upgrade
|
| Income Tax Expense | 2.5 | 2.36 | 2.3 | 1.76 | 1.35 | 2.04 | Upgrade
|
| Earnings From Continuing Operations | 6.09 | 5.72 | 5.95 | 3.95 | 3.96 | 2.87 | Upgrade
|
| Minority Interest in Earnings | -0.02 | -0.02 | -0.02 | -0.02 | -0.03 | -0.03 | Upgrade
|
| Net Income | 6.07 | 5.7 | 5.93 | 3.93 | 3.93 | 2.84 | Upgrade
|
| Preferred Dividends & Other Adjustments | 0.07 | 0.08 | - | - | - | - | Upgrade
|
| Net Income to Common | 6 | 5.62 | 5.93 | 3.93 | 3.93 | 2.84 | Upgrade
|
| Net Income Growth | -0.77% | -3.81% | 50.96% | -0.03% | 38.34% | -56.41% | Upgrade
|
| Shares Outstanding (Basic) | 11 | 11 | 11 | 11 | 11 | - | Upgrade
|
| Shares Outstanding (Diluted) | 11 | 11 | 11 | 11 | 11 | - | Upgrade
|
| EPS (Basic) | 0.52 | 0.49 | 0.52 | 0.34 | 0.34 | - | Upgrade
|
| EPS (Diluted) | 0.52 | 0.49 | 0.52 | 0.34 | 0.34 | - | Upgrade
|
| EPS Growth | -1.97% | -5.18% | 50.96% | -0.03% | - | - | Upgrade
|
| Free Cash Flow | 6.3 | -3.01 | 2.1 | 10.69 | 9.78 | -3.06 | Upgrade
|
| Free Cash Flow Per Share | 0.55 | -0.26 | 0.18 | 0.93 | 0.86 | - | Upgrade
|
| Dividend Per Share | - | - | 0.175 | 0.130 | 0.220 | - | Upgrade
|
| Dividend Growth | - | - | 34.60% | -40.91% | - | - | Upgrade
|
| Gross Margin | 31.02% | 30.93% | 30.30% | 30.99% | 29.62% | 31.15% | Upgrade
|
| Operating Margin | 14.34% | 14.09% | 15.51% | 11.91% | 12.69% | 14.78% | Upgrade
|
| Profit Margin | 9.84% | 9.46% | 11.08% | 8.77% | 9.09% | 5.60% | Upgrade
|
| Free Cash Flow Margin | 10.34% | -5.07% | 3.93% | 23.88% | 22.63% | -6.03% | Upgrade
|
| EBITDA | 11.12 | 10.89 | 10.27 | 6.98 | 6.73 | 8.63 | Upgrade
|
| EBITDA Margin | 18.25% | 18.33% | 19.21% | 15.59% | 15.58% | 17.02% | Upgrade
|
| D&A For EBITDA | 2.38 | 2.52 | 1.98 | 1.65 | 1.25 | 1.13 | Upgrade
|
| EBIT | 8.74 | 8.37 | 8.3 | 5.33 | 5.48 | 7.49 | Upgrade
|
| EBIT Margin | 14.34% | 14.09% | 15.51% | 11.91% | 12.69% | 14.78% | Upgrade
|
| Effective Tax Rate | 29.06% | 29.19% | 27.87% | 30.77% | 25.44% | 41.58% | Upgrade
|
| Revenue as Reported | 61.79 | 60.22 | 54.59 | 45.62 | 44.09 | 50.69 | Upgrade
|
| Advertising Expenses | - | 1.32 | 0.52 | 0.53 | 0.38 | 0.73 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.